Drug intelligence / Profile preview

Alamin SN

Development stage
Unknown
Lead developer
Albert David
Modality
Small Molecules
Administration
Intravenous
01

Overview

Alamin SN is a parenteral nutrition supplement containing a balanced mixture of 18 pure crystalline amino acids, including eight essential amino acids. Manufactured by Albert David Limited, it is designed for intravenous administration to maintain a positive nitrogen balance and support protein synthesis in patients who cannot receive adequate oral or enteral nutrition. In clinical settings, Alamin SN is also utilized to induce nutrient-induced thermogenesis, which can help prevent peri-operative hypothermia and shivering, particularly during cesarean sections under spinal anesthesia. The solution provides the necessary substrates for cellular metabolism and energy expenditure without significantly increasing sympathoadrenal activity.

Brand names
Alamin SN
Other names
18 Amino Acids InjectionCrystalline Amino Acid Solution
02

Targets

Neuraminidase

Beyond the preview

Go deeper on Alamin SN.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alamin SN.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call